iANTHUS CAPITAL HOLDINGS (ITHUF) Cash & Current Investments (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Cash & Current Investments came in at $11.2 million in Q1 2026, down 55.27% year-on-year from $25.1 million in Q1 2025, and down 5.56% quarter-over-quarter from $11.9 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Cash & Current Investments (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Cash & Current Investments across 7 years of filings, most recently posting $11.2 million for Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $11.2 million, down 55.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.2 million (down 55.27% YoY), and the FY2025 annual result was $11.9 million, down 37.85% from the prior year.
- Cash & Current Investments came in at $11.2 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from $11.9 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $25.1 million in Q1 2025 to a low of $70000.0 in Q3 2022.
- The 5-year median for Cash & Current Investments is $12.4 million (2023), against an average of $12.0 million.
- Across the five-year window, Cash & Current Investments slumped 98.31% in 2022 and soared 21577.14% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Cash & Current Investments stood at $100000.0 in 2022, then surged by 650.0% to $750000.0 in 2023, then surged by 2446.53% to $19.1 million in 2024, then slumped by 37.85% to $11.9 million in 2025, then retreated by 5.56% to $11.2 million in 2026.
- The last three Cash & Current Investments figures came in at $11.2 million (Q1 2026), $11.9 million (Q4 2025), and $17.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 11.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.21 Mn |
| Dec 31, 2025 | 11.87 Mn |
| Sep 30, 2025 | 17.93 Mn |
| Jun 30, 2025 | 23.94 Mn |
| Mar 31, 2025 | 25.06 Mn |
| Dec 31, 2024 | 19.10 Mn |
| Sep 30, 2024 | 20.86 Mn |
| Jun 30, 2024 | 16.94 Mn |
| Mar 31, 2024 | 13.73 Mn |
| Dec 31, 2023 | 750,000.00 |
| Sep 30, 2023 | 15.17 Mn |
| Jun 30, 2023 | 10.14 Mn |
| Mar 31, 2023 | 12.37 Mn |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 70,000.00 |
| Jun 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | 2.64 Mn |
| Dec 31, 2021 | 3.90 Mn |
| Sep 30, 2021 | 4.14 Mn |
| Jun 30, 2021 | 5.71 Mn |